The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53.
APi Group Corp
APG · the NYSE · USD · Market cap $17.2B · 29,000 employees
APi Group Corporation provides fire and life safety, security, elevator and escalator, and specialty services worldwide.
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago
Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price43.47 USD at the 13 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 13 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenDoes not pass
- OptionsOpen interest leans to puts (put/call 65.14)
- Last reviewed13 Nov 2026 (4 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $45.00 to $55.19, base estimate $47.99 (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 65.14, read 2026-11-13
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
APi Group Corp holds its Markup at $43.47. The statistical read favours the buyers, held for 6 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 6 days |
| Price at the screen | $43.47 |
| Valuation | N/A trailing · 19.68 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.58 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 34.38% | Below 33% | Interest-bearing debt is 34.4% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 27.70% | Below 49% | Money owed to the company is 27.7% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
APi's business is in a permissible area, but its interest-bearing debt is about 34% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when APG's ethical verdict changes
Today APG does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 9% discount to our $47.99 fair value, narrow competitive moat, 22.50% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 9.4% discount to the base estimate.
Third-party analyst targets: 11 covering, consensus Strong Buy. The average target sits +27% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $47.99, with a range of $45.00 to $55.19, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFire safety contracts keep buildings running
Picture every new office tower or hospital wing that needs sprinklers, alarms and lifts installed on time. APi Group handles that work across two service lines and is growing revenue at 15 percent a year. The shares sit 13 percent below our fair value, the ethical screen is clear, yet the opportunity rating stays at none.
The business earns a narrow moat, a 4 percent profit margin and 10 percent return on equity. Those figures, paired with a 20.1 times forward multiple, leave little room for error once construction cycles turn. Analyst targets sit higher, but the numbers do not clear the threshold for a positive call.
Currency swings and project delays in the engineering sector add real volatility. Low margins mean any cost overrun quickly eats returns. Analysis, not advice.
| Forward P/E | 19.7xfairly priced for its growth rate |
| EPS, trailing | -0.57 |
| EPS, forward | 2.05 |
| Revenue growth | +22.5%strong top-line growth |
| Profit margin | 4.1%barely profitable |
| Return on equity | 10.9%a modest return on shareholder capital |
| FCF yield | 3.59% |
| Debt to equity | 1.12a meaningful debt load worth watching |
| Current ratio | 1.18adequate liquidity, worth monitoring |
| Beta | 1.58much more volatile than the market |
| Short interest, float | 0.03% |
| 52-week range | 35.16 - 49.99 |
| Moat | NARROW |
| Market cap | $17.2B |
| Employees | 29,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeAPG trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 32%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it strong buy, with a mean price target of $53. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Is APi Group (APG) Stock Outpacing Its Business Services Peers This Year? Yahoo Finance · 8d ago
- APi (APG) is an Incredible Growth Stock: 3 Reasons Why Yahoo Finance · 10d ago
- Wall Street Analysts See a 36.62% Upside in APi (APG): Can the Stock Really Move This High? Yahoo Finance · 11d ago
- Does The Fall In MasTec Stock Change Anything? Yahoo Finance · 11d ago
- Resilient Demand and Recurring Revenue Drive APi Group’s (APG) Strong Investment Case Yahoo Finance · 12d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-04 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-08-04 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-08-04 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-08-04 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-08-04 | Gil Cisneros | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $44.12 | -4.7% | · | $953 | -4.7% |
| 2 months | $44.41 | -5.3% | · | $947 | -5.3% |
| 3 months | $40.78 | +3.1% | · | $1,031 | +3.1% |
| 6 months | $40.40 | +4.1% | · | $1,041 | +4.1% |
| 1 year | $31.77 | +32.3% | · | $1,323 | +32.3% |
| 2 years | $25.13 | +67.4% | · | $1,674 | +67.4% |
| 3 years | $16.41 | +156.3% | · | $2,563 | +156.3% |
| 5 years | $14.90 | +182.2% | · | $2,822 | +182.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever APG does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.